Forest Seeks Injunction Against Lexapro Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest filed a motion for preliminary injunction to prevent Cipla and Ivax from marketing generic versions of Lexapro (escitalopram) in Delaware federal court on Jan. 13
You may also be interested in...
Alphapharm To Market “Authorized” Generic Of Forest’s Lexapro
Deal allows Alphapharm to launch two weeks before the escitalopram patent expires in December 2009.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.